Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Hyogo, Japan.
Biochem Biophys Res Commun. 2022 May 7;603:123-129. doi: 10.1016/j.bbrc.2022.02.113. Epub 2022 Mar 6.
Cisplatin (CDDP) is an effective anticancer drug for the treatment of malignant tumors, such as lung cancer, bladder cancer, and testicular cancer. However, oligozoospermia and azoospermia after administration of CDDP are clinical problems. One of the testicular toxicities of CDDP is known to cause oxidative stress. Tadalafil has been reported to exhibit antioxidant effects and is widely used in clinical practice to treat benign prostatic hyperplasia and erectile dysfunction. Rho-kinase α (ROCK2) regulates cell migration and apoptosis and has been reported to be involved in CDDP-induced nephrotoxicity. The excessive expression of ROCK2 is known to cause oxidative stress.
The objective of the current study was to test the effect of tadalafil on the testicular toxicity of CDDP.
Thirty-two rats were used and divided into the following four groups. (1) The control group (CONT), treated with saline on day 1 and saline and dimethyl sulfoxide (DMSO) on days 1-10 intraperitoneally (i.p.) (2) The Tadalafil Group (TAD), treated with saline on day 1, and 0.4 mg/kg tadalafil on days 1-10 i.p. (3) The CDDP group (CD), treated with 7 mg/kg CDDP, saline, and DMSO on days 1-10 i.p. and (4) The CDDP + TAD group (CDT) was treated with 7 mg/kg CDDP on day 1, and 0.4 mg/kg tadalafil on days 1-10 i.p. Testes and epididymides samples were collected on day 11. Biochemical and pathological analyses and quantitative polymerase chain reaction were performed on the excised specimens.
CDDP treatment resulted in testicular atrophy, decreased sperm concentration, and atrophy of seminiferous tubules as observed from the testicular histology. Increased apoptosis of seminiferous tubules, oxidative stress, and ROCK2 mRNA expression were observed after CDDP treatment. Treatment with tadalafil improved these adverse effects.
Tadalafil is a potential drug for reducing CDDP-induced spermatogenic dysfunction. The antioxidant effect of tadalafil may be partly responsible for this phenomenon. ROCK2 and oxidative stress markers may be involved in the possible antioxidant effects of tadalafil. Tadalafil may be considered as one of a treatment option for reducing spermatogenic dysfunction after administration of CDDP.
顺铂(CDDP)是一种有效的抗癌药物,可用于治疗肺癌、膀胱癌和睾丸癌等恶性肿瘤。然而,顺铂治疗后出现少精子症和无精子症是临床问题。顺铂的一种睾丸毒性已知会导致氧化应激。他达拉非已被报道具有抗氧化作用,广泛用于临床实践中治疗良性前列腺增生和勃起功能障碍。Rho-激酶α(ROCK2)调节细胞迁移和凋亡,据报道与顺铂诱导的肾毒性有关。ROCK2 的过度表达已知会导致氧化应激。
本研究旨在测试他达拉非对顺铂睾丸毒性的影响。
使用 32 只大鼠,分为以下四组。(1)对照组(CONT),第 1 天给予生理盐水,第 1-10 天给予生理盐水和二甲基亚砜(DMSO)腹腔内(i.p.)注射;(2)他达拉非组(TAD),第 1 天给予生理盐水,第 1-10 天给予 0.4mg/kg 他达拉非腹腔内注射;(3)顺铂组(CD),第 1 天给予 7mg/kg 顺铂,第 1-10 天给予生理盐水和 DMSO 腹腔内注射;(4)顺铂+他达拉非组(CDT),第 1 天给予 7mg/kg 顺铂,第 1-10 天给予 0.4mg/kg 他达拉非腹腔内注射。第 11 天采集睾丸和附睾样本。对切除的标本进行生化和病理分析及定量聚合酶链反应。
顺铂治疗导致睾丸萎缩、精子浓度降低和精曲小管萎缩,从睾丸组织学观察到。顺铂治疗后观察到精曲小管凋亡增加、氧化应激和 ROCK2mRNA 表达增加。他达拉非治疗改善了这些不良反应。
他达拉非是一种减少顺铂诱导的生精功能障碍的潜在药物。他达拉非的抗氧化作用可能部分与此现象有关。ROCK2 和氧化应激标志物可能参与他达拉非的可能抗氧化作用。他达拉非可作为减少顺铂治疗后生精功能障碍的治疗选择之一。